Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites
- PMID: 20447913
- PMCID: PMC2867075
- DOI: 10.1158/1055-9965.EPI-09-1303
Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites
Abstract
Background: We sought to determine the optimal plasma and urine nicotine metabolites, alone or in combination, to estimate the systemic dose of nicotine after low-level exposure.
Methods: We dosed 36 nonsmokers with 100, 200, or 400 microg p.o. of deuterium-labeled nicotine (doses similar to exposure to secondhand smoke) daily for 5 days and then measured plasma and urine nicotine metabolites at various intervals over 24 hours.
Results: The strongest correlations with nicotine dose were seen for the sum of four (cotinine+cotinine-glucuronide+trans-3'-hydroxycotinine+3HC-glucuronide) or six (including also nicotine+nicotine-glucuronide) of the major nicotine metabolites in 24-hour urine collection (r=0.96), with lesser correlations for these metabolites using spot urines corrected for creatinine at various times of day (r=0.72-0.80). The sum of plasma cotinine+trans-3'-hydroxycotine was more highly correlated with nicotine dose than plasma cotinine alone (r=0.82 versus 0.75).
Conclusions: Our results provide guidance for the selection of biomarkers to estimate the dose of nicotine taken in low-level (secondhand smoke) tobacco exposure.
Impact: This is probably relevant to active smoking as well.
Copyright (c) 2010 AACR
Figures




Similar articles
-
Biomarkers of secondhand smoke exposure in automobiles.Tob Control. 2014 Jan;23(1):51-7. doi: 10.1136/tobaccocontrol-2012-050724. Epub 2013 Jan 24. Tob Control. 2014. PMID: 23349229 Free PMC article.
-
Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure.Nicotine Tob Res. 2009 Aug;11(8):954-60. doi: 10.1093/ntr/ntp092. Epub 2009 Jun 12. Nicotine Tob Res. 2009. PMID: 19525206 Free PMC article.
-
Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 1;879(3-4):267-76. doi: 10.1016/j.jchromb.2010.12.012. Epub 2010 Dec 21. J Chromatogr B Analyt Technol Biomed Life Sci. 2011. PMID: 21208832 Free PMC article.
-
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology.Ther Drug Monit. 2009 Feb;31(1):14-30. doi: 10.1097/FTD.0b013e3181957a3b. Ther Drug Monit. 2009. PMID: 19125149 Free PMC article. Review.
-
[The exposure to tobacco smoking].Przegl Lek. 2002;59(4-5):358-63. Przegl Lek. 2002. PMID: 12184007 Review. Polish.
Cited by
-
Cigarette consumption and biomarkers of nicotine exposure during pregnancy and postpartum.Addiction. 2018 Nov;113(11):2087-2096. doi: 10.1111/add.14367. Epub 2018 Jul 23. Addiction. 2018. PMID: 29920836 Free PMC article.
-
Tobacco toxicant exposure in cigarette smokers who use or do not use other tobacco products.Drug Alcohol Depend. 2017 Oct 1;179:330-336. doi: 10.1016/j.drugalcdep.2017.07.021. Epub 2017 Aug 16. Drug Alcohol Depend. 2017. PMID: 28843083 Free PMC article.
-
Biochemical Verification of Tobacco Use and Abstinence: 2019 Update.Nicotine Tob Res. 2020 Jun 12;22(7):1086-1097. doi: 10.1093/ntr/ntz132. Nicotine Tob Res. 2020. PMID: 31570931 Free PMC article. Review.
-
Correlates of the nicotine metabolite ratio in Alaska Native people who smoke cigarettes.Exp Clin Psychopharmacol. 2022 Jun;30(3):359-364. doi: 10.1037/pha0000461. Epub 2021 Apr 15. Exp Clin Psychopharmacol. 2022. PMID: 33856821 Free PMC article. Clinical Trial.
-
Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.Pharmacol Biochem Behav. 2016 Sep;148:1-7. doi: 10.1016/j.pbb.2016.05.002. Epub 2016 May 11. Pharmacol Biochem Behav. 2016. PMID: 27180107 Free PMC article. Clinical Trial.
References
-
- Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188–204. - PubMed
-
- Benowitz NL, Jacob P, III, Fong I, Gupta S. Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther. 1994;268:296–303. - PubMed
-
- Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev. 2005;14:2963–8. - PubMed
-
- Feng S, Kapur S, Sarkar M, et al. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicol Lett. 2007;173:101–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources